Polina O. Fedorova

Polina O. Fedorova

Auto-generated profile, based on publicly available information

Polina O. Fedorova

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2020 in Journal of microbiology, epidemiology and immunobiology
Verified
Journal Article
Open access
PDF file
ПШПолина Олеговна Шатунова
Полина Олеговна Шатунова
АБАнатолий Сергеевич Быков
Анатолий Сергеевич Быков
ОСОксана Анатольевна Свитич
Оксана Анатольевна Свитич
ВЗВиталий Васильевич Зверев
Виталий Васильевич Зверев
The SARS-CoV-2 virus is a pathogen causing the coronavirus infection that culminated in a worldwide pandemic in 2020. It belongs to β-coronaviruses and has high genetic similarity to the SARS-CoV virus that is responsible for an outbreak of severe acute respiratory syndrome in 2002–2003. The analysis of molecular interactions shows that SARS-CoV-2 has higher virulence due to lower binding free energy in interaction with the angiotensin-converting enzyme 2 (ACE2), which is used by the virus to enter the host cell. At the time of the global coronavirus pandemic, the thorough study of ACE2 as a key component of the disease pathogenesis comes to the fore. The detailed study of the enzyme, which is a receptor located on the surface of different tissues and which normally catalyzes the conversion of angiotensin II to angiotensin (1–7), led to diverging conclusions. Being non-tissue specific, the receptor is abundantly present in the heart, kidneys, small intestine, testes, thyroid, and adipose tissue. Besides regulating blood pressure, it suppresses inflammation, mainly in the lung tissue, participates in amino acid transport and maintains the activity of the gut microbiome. With all its essential positive functions, the role of ACE2 is highly ambiguous, specifically in coronavirus infection. The influence on the renin-angiotensin system can be seen as a promising therapeutic route in treatment of coronavirus infection. The preliminary data on using of ACE2 inhibitors, soluble forms of ACE2, and angiotensin II receptor blockers demonstrate their effectiveness and, consequently, improvement in symptoms and prognoses for patients with coronavirus infection. The review presents information about ACE2 distribution in human tissues, explores its interaction with SARS-CoV-2, provides a theoretical basis for medications involving ACE2 metabolic pathways and for using them in treatment of coronavirus infection and its prevention.

18 September 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
ICIrina Chikileva
Irina Chikileva
ABAlexandra Bruter
Alexandra Bruter
NPNadezhda A. Persiyantseva
Nadezhda A. Persiyantseva
MZMaria Zamkova
Maria Zamkova
RVRaimonda Ya. Vlasenko
Raimonda Ya. Vlasenko
Mikhail KiselevskiyMikhail Kiselevskiy
Mikhail Kiselevskiy
Human epidermal growth factor receptor 2 (HER2) is overexpressed in numerous cancer cell types. Therapeutic antibodies and chimeric antigen receptors (CARs) against HER2 were developed to treat human tumors. The major limitation of anti-HER2 CAR-T lymphocyte therapy is attributable to the low HER2 expression in a wide range of normal tissues. Thus, side effects are caused by CAR lymphocyte “on-target off-tumor” reactions. We aimed to develop safer HER2-targeting CAR-based therapy. CAR constructs against HER2 tumor-associated antigen (TAA) for transient expression were delivered into target T and natural killer (NK) cells by an effective and safe non-viral transfection method via nucleofection, excluding the risk of mutations associated with viral transduction. Different in vitro end-point and real-time assays of the CAR lymphocyte antitumor cytotoxicity and in vivo human HER2-positive tumor xenograft mice model proved potent cytotoxic activity of the generated CAR-T-NK cells. Our data suggest transient expression of anti-HER2 CARs in plasmid vectors by human lymphocytes as a safer treatment for HER2-positive human cancers. We also conducted preliminary investigations to elucidate if fucosylated chondroitin sulfate may be used as a possible agent to decrease excessive cytokine production without negative impact on the CAR lymphocyte antitumor effect.

16 May 2024 in Exploration of Medicine
Verified
Journal Article
Open access
PDF file
ICIrina Chikileva
Irina Chikileva
PFPolina Fedorova
Polina Fedorova
Irina ShubinaIrina Shubina
Irina Shubina
SPStanislav Pshenichnikov
Stanislav Pshenichnikov
KLKateryna Levada
Kateryna Levada
Mikhail KiselevskiyMikhail Kiselevskiy
Mikhail Kiselevskiy
Therapy of malignant tumors still represents a huge problem for healthcare, since these diseases lead to a high rate of disability and premature death of the population. The main problems of adoptive cell therapy for malignant tumors are a low rate of migration of effector lymphocytes into tumors, as well as their low activity in tumors due to suppressive tumor microenvironment. In addition, it should be noted that systemic intravenous administration of a large number of activated lymphocytes may be accompanied by a pronounced cytokine release syndrome, which leads to significant negative side effects, including high temperature, blood clotting disorders, aggression of immune cells against their own tissues, even neurotoxicity. Functional nanomaterials, such as magnetic nanoparticles with various surface modifications (PEG, PEI, DMSA, citrate, etc.) are highly promising agents for targeted delivery of different anti-tumor substances. Magnet-driven enrichment of effector anti-tumor lymphocytes in tumors would highly increase the effectiveness and enhance safety of adoptive lymphocyte therapy. However, different research groups obtained opposing data about the feasibility and efficiency of such approach. Thus, this review is focused on experimental details of the contradicting studies and aims to elucidate the possible reasons of these controversies and the best practices to efficiently target lymphocytes into tumors.

17 December 2025 in Russian Journal of Biotherapy
Verified
Journal Article
Open access
PDF file
PFPolina O. Fedorova
Polina O. Fedorova
ICIrina Chikileva
Irina Chikileva
ATAlexandra Tokatly
Alexandra Tokatly
AUAnatoly I. Usov
Anatoly I. Usov
MBMaria I. Bilan
Maria I. Bilan
Mikhail KiselevskiyMikhail Kiselevskiy
Mikhail Kiselevskiy
Introduction. Ex vivo expansion of natural killer (NK) and natural killer T-cells (NKT) cells is an important element in the generation of chimeric antigen receptor NK and NKT cells. Monoclonal antibodies (mAbs) to CD (cluster of differentiation) 3 and CD28 receptors are most often used for lymphocyte expansion. Other well-studied T-cell mitogens include phytohaemagglutinin-L (L-PHA) and concanavalin A (ConA). A promising but poorly studied approach is in vitro activation of immune cells with the polysaccharide fucosylated chondroitin sulfate (FCS) isolated from the sea cucumber Cucumaria japonica, which is able to activate immune cells and stimulate hematopoiesis. Aim. To identify the optimal method for NK and NKT cell activation in primary lymphocyte culture. For this purpose, we tested mAbs to CD3 and CD28 receptors, L-PHA, ConA, and a combination of mAbs to CD3 and CD28 receptors and FCS. Materials and methods. Peripheral blood and leukocyte-platelet concentrate were used as a source of peripheral blood mononuclear cells (PBMC). After isolation of PBMC, they were activated using adsorbed mAbs to CD3 and CD28 receptors, L-PHA, ConA, or a mAbs + FCS combination. Then, lymphocytes were cultured in the presence of IL-2, periodically assessing the increase in the total number of cells, expression of surface markers, and cytotoxic activity. Results. It was shown that L-PHA best stimulated the expansion of T lymphocytes (CD3+CD56–) and NK cells (CD3–CD56+) relative to other activation modes. Under the influence of ConA, the division of CD3+CD4+ lymphocytes was significantly activated. When comparing the activation of cells under the influence of MAT relative to L-PHA and ConA, the most pronounced increase in the CD3+CD56+ population was observed. The addition of FCS during MAT stimulation led to an increase in lymphocyte proliferation. Conclusion. Thus, among the presented methods of PBMC activation for stimulating the expansion of NK and NKT cells, the most preferable was the MAT + FCS activation method, since it resulted in the greatest increase in the total number of cells with a maximum proportion of CD56+ lymphocytes, amounting to 58.9% by the end of the culturing period.

8 December 2025 in Russian Journal of Infection and Immunity
Verified
Journal Article
Open access
PFPolina O. Fedorova
Polina O. Fedorova
ICIrina Chikileva
Irina Chikileva
Mikhail KiselevskiyMikhail Kiselevskiy
Mikhail Kiselevskiy
КВКиселевский Михаил Валентинович
Киселевский Михаил Валентинович
While creating chimeric antigen receptor (CAR) NK cells, it is necessary to conduct a stage of these immune cell enrichment. Feeder cells are most often used in methods for the effective NK cell expansion. The human embryonic kidney cell line containing the SV40 T-antigen (HEK 293T) is most often used for research purposes in various areas, since it is easily subjected to genetic modifications. This property indicates the potential for modifying HEK 293T cells to express tumor antigens or proinflammatory cytokines, which can be used to activate and enrich NK cells. In this work, we assessed the effect of unmodified HEK 293T cell culture on cytotoxicity and expression of NK and NKT cell activation markers in long-term cultivation in the presence of non-irradiated autologous feeder cells. The study used peripheral blood mononuclear cells collected from healthy volunteer donors. Proliferation was stimulated using antibodies against CD3 and CD28 receptors or mitomycin C-treated HEK 293T cell culture. Cell proliferation was assessed by direct cell counting added with trypan blue dye. Cytotoxicity was determined on HG3, T47D-HER2+, K562 target cultures. Flow cytometry with labeled monoclonal antibodies was used to analyze the expression of surface receptors. Four different methods for lymphocyte activation using HEK 293T were proposed. We found that when using the HEK 293T cell line, an increased percentage of CD3–CD56+ cells in the population was observed in all activation modes, as well as increased expression of NK cell activation markers — NKp30 and NKG2D, in addition, the proportion of CD16+ and CD3+CD4+ lymphocytes increased relative to activation with monoclonal antibodies alone. Of the proposed options for coincubation of lymphocytes with HEK 293T feeder cells, the most effective NK cells expansion was described for the protocol involving the use of the HEK 293T cell line once before the onset of incubation without proliferation additionally stimulated with monoclonal antibodies. This approach resulted in higher proportion of CD56+ lymphocytes reaching to 60% as early as on day 4 of cultivation. Thus, HEK 293T cells stimulate NK cells division, therefore, they can be used as feeder cells in a CAR NK cell product development.

17 October 2023 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
PSP. O. Shatunova
P. O. Shatunova
MGM. V. Gavrilova
M. V. Gavrilova
ARArtem Rtishchev
Artem Rtishchev
TKTatiana Kolyganova
Tatiana Kolyganova
TZT. A. Zaytseva
T. A. Zaytseva
SMS. G. Markushin
S. G. Markushin
The avian influenza virus (AIV) has a great pandemic potential both in animals, and in human population. For effective struggle against this virus, it is important to study the immune response against AIV, and, in particular, the features of T cell immunity. At the period of early immune response, when the activation of adaptive immunity factors has not yet occurred, the natural killers, which have both cytotoxic and immunoregulatory functions, are known to play a key role in the fight against the influenza virus. In this study, we investigated the interaction between natural killers and T helpers in the process of antiviral response. The aim of this study was to study immunoregulatory functions of NK cells in BALB/c mice vaccinated with different doses of avian influenza virus.We used a strain of mouse-adapted avian influenza virus (AIV) of the H5N2 serotype (A/duck/ Pennsylvania/10218/1984). The determination of the virus titer in the mice lung tissue was performed by infecting 10-day-old chicken embryos (SPF) with lung extracts at various decimal dilutions, followed by the immune agglutination test. Quantitative determination of natural killers and T helpers (Th) in the mice spleen tissue was carried out by flow cytometry. The amount of Th cells in mice spleens increased at low infectious dose (2.5 EID50) which is explained by active clonal expansion of this cell subpopulation. The infectious disease process ended upon complete virus elimination from the lungs. The amounts of Th cells were also increased in a group of mice infected with intermediate infectious dose (25 EID50), however, being accompanied by virus replication in lungs. When the mice were infected with a high dose of the virus (250 EID50), there was a decrease in the Th cells number versus control group of animals, whereas replication of AIV was noted throughout the entire observation period in the lung tissue.The amounts of helper T cells at high doses of viral infection could be decreased due to activation of NK cells. The activated NK cells may then eliminate exhausted helper T cells. Thus, NK cells immunoregulatory function represents an important immunological factor which keeps balance between the pathogen destruction and excessive inflammation of the lung tissue affected by the avian influenza virus.